Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression

World Journal of Gastroenterology

Volumn 22, Issue 4, 2016, Pages 1382-1392

  Tovo, Pier Angelo ^a   Calitri, Carmelina ^a   Scolfaro, Carlo ^a   Gabiano, Clara ^a   Garazzino, Silvia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Disease progression; Hepatitis C virus; Pediatrics; Risk factors; Spontaneous viral clearance; Vertical transmission

Indexed keywords

ANTIRETROVIRUS AGENT; AUTOANTIBODY; CRYOGLOBULIN; INTERLEUKIN 28B; ANTIVIRUS AGENT;

AMNIOCENTESIS; ANTIRETROVIRAL THERAPY; ARTICLE; ASYMPTOMATIC DISEASE; BREAST FEEDING; CESAREAN SECTION; CHRONIC INFECTION; COINFECTION; DISEASE EXACERBATION; ELECTIVE SURGERY; FETUS MONITORING; GENETIC BACKGROUND; GENETIC POLYMORPHISM; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IL28B GENE; MATERNAL BLOOD; MOTHER TO CHILD TRANSMISSION; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIMARY INFECTION; QUASISPECIES; RISK FACTOR; RISK REDUCTION; VIRAL CLEARANCE; VIRAL CONTAMINATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; AGE; DISEASE COURSE; FEMALE; HEPACIVIRUS; MIXED INFECTION; PATHOGENICITY; REMISSION; TRANSMISSION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIROLOGY;

AGE FACTORS; ANTIVIRAL AGENTS; COINFECTION; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 85016489420     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/WJG.V22.I4.1382     Document Type: Article

References (133)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362 [PMID: 2523562 DOI: 10.1126/science.2523562]
2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-115 [PMID: 21091831 DOI: 10.1111/j.1469-0691.2010.03432.x]
3. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57 [PMID: 25086286 DOI: 10.1016/j.jhep.2014.07.027]
4. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141]
5. Wedemeyer H, Dore GJ, Ward JW. Estimates on HCV disease burden worldwide - filling the gaps. J Viral Hepat 2015; 22 Suppl 1: 1-5 [PMID: 25560838 DOI: 10.1111/jvh.12371]
6. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13: 288 [PMID: 23799878 DOI: 10.1186/1471-2334-13-288]
7. Gimelfarb A. Pleiotropy and multilocus polymorphisms. Genetics 1992; 130: 223-227 [PMID: 1732163 DOI: 10.1016/j.jhep.2006.12.014]
8. Akhtar S, Moatter T. Intra-household clustering of hepatitis C virus infection in Karachi, Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 535-539 [PMID: 15251402 DOI: 10.1016/j.trstmh.2003.12.010]
9. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA 2010; 107: 14757-14762 [PMID: 20696911 DOI: 10.1073/pnas.1008877107]
10. Schwimmer JB, Balistreri WF. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin Liver Dis 2000; 20: 37-46 [PMID: 10895430 DOI: 10.1055/s-2000-9257]
11. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T, Akhtar S, Hamid S, Shah HA, Nizami SQ. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 6: 101 [PMID: 16792819 DOI: 10.1186/1471-2334-6-101]
12. El-Shabrawi MH, Kamal NM. Burden of pediatric hepatitis C. World J Gastroenterol 2013; 19: 7880-7888 [PMID: 24307782 DOI: 10.3748/wjg.v19.i44.7880]
13. Zahran KM, Badary MS, Agban MN, Abdel Aziz NH. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women’s Health Center of Assiut University, Upper Egypt. Int J Gynaecol Obstet 2010; 111: 171-174 [PMID: 20708181 DOI: 10.1016/j.ijgo.2010.06.013]
14. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period-are they opportunities for treatment? J Viral Hepat 2011; 18: 229-236 [PMID: 21392169 DOI: 10.1111/j.1365-2893.2010.01413.x]
15. Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012; 4: 3531-3550 [PMID: 23223189 DOI: 10.3390/v4123531]
16. Floreani A. Hepatitis C and pregnancy. World J Gastroenterol 2013; 19: 6714-6720 [PMID: 24187446 DOI: 10.3748/wjg.v19. i40.6714]
17. Locatelli A, Roncaglia N, Arreghini A, Bellini P, Vergani P, Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999; 106: 498-500 [PMID: 10430202 DOI: 10.1111/j.1471-0528.1999. tb08305.x]
18. Paternoster DM, Fabris F, Palù G, Santarossa C, Bracciante R, Snijders D, Floreani A. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002; 81: 99-103 [PMID: 11942897 DOI: 10.1034/j.1600-0412.2002.810202.x]
19. Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol 2014; 34: 882-891 [PMID: 25233195 DOI: 10.1038/jp.2014.167]
20. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751-755 [PMID: 10706568 DOI: 10.1002/hep.510310328]
21. Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, Kilani A, Erlinger S, Valla D, Marcellin P. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000; 32: 293-299 [PMID: 10707870 DOI: 10.1016/S0168-8278(00)80075-6]
22. Paternoster DM, Santarossa C, Grella P, Palù G, Baldo V, Boccagni P, Floreani A. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001; 96: 2751-2754 [PMID: 11569706 DOI: 10.1111/j.1572-0241.2001.04135.x]
23. Vento S, Longhi MS, Cainelli F, Concia E. Effect of pregnancy on chronic hepatitis C. Lancet 2001; 357: 389-390 [PMID: 11211018 DOI: 10.1016/S0140-6736(05)71517-8]
24. Geissler W. [Active rehabilitation of myocardial infarct]. Z Arztl Fortbild (Jena) 1975; 29: 306-308 [PMID: 1220308 DOI: 10.1007/s005350200105]
25. Latt NC, Spencer JD, Beeby PJ, McCaughan GW, Saunders JB, Collins E, Cossart YE. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 2000; 15: 175-181 [PMID: 10735542 DOI: 10.1046/j.1440-1746.2000.02060.x]
26. Munoz-Suano A, Hamilton AB, Betz AG. Gimme shelter: the immune system during pregnancy. Immunol Rev 2011; 241: 20-38 [PMID: 21488887 DOI: 10.1111/j.1600-065X.2011.01002.x]
27. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997; 37: 368-377 [PMID: 9196795 DOI: 10.1111/j.1600-0897.1997.tb00246.x]
28. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004; 112: 38-43 [PMID: 15096182 DOI: 10.1111/j.1365-2567.2004.01869.x]
29. Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int 2010; 30: 765-770 [PMID: 20214739 DOI: 10.1111/j.1478-3231.2010.02218.x]
30. Jabeen T, Cannon B, Hogan J, Crowley M, Devereux C, Fanning L, Kenny-Walsh E, Shanahan F, Whelton MJ. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 2000; 93: 597-601 [PMID: 10984554 DOI: 10.1093/qjmed/93.9.597]
31. Floreani A, Paternoster D, Zappala F, Cusinato R, Bombi G, Grella P, Chiaramonte M. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996; 103: 325-329 [PMID: 8605128 DOI: 10.1111/j.1471-0528.1996.tb09736.x]
32. Garazzino S, Calitri C, Versace A, Alfarano A, Scolfaro C, Bertaina C, Vatrano S, Mignone F, Licciardi F, Gabiano C, Tovo PA. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur J Pediatr 2014; 173: 1025-1031 [PMID: 24585099 DOI: 10.1007/s00431-014-2286-6]
33. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994; 330: 744-750 [PMID: 8107740 DOI: 10.1056/NEJM199403173301103]
34. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D’Amico E, Cambiè G, Vecchi L. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995; 345: 289-291 [PMID: 7530793 DOI: 10.1016/S0140-6736(95)90277-5]
35. Tovo PA, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P, Maccabruni A. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 1997; 25: 1121-1124 [PMID: 9402369 DOI: 10.1086/516102]
36. Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, de Martino M, Vierucci A. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317: 437-441 [PMID: 9703524 DOI: 10.1136/bmj.317.7156.43]
37. European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network. BJOG 2001; 108: 371-377 [PMID: 11305543 DOI: 10.1111/j.1471-0528.2001.00088.x]
38. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005; 192: 1872-1879 [PMID: 16267757 DOI: 10.1086/497695]
39. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-1889 [PMID: 16267758 DOI: 10.1086/497701]
40. Tovo PA, Lazier L, Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 2005; 18: 261-266 [PMID: 15864105]
41. Mariné-Barjoan E, Berrébi A, Giordanengo V, Favre SF, Haas H, Moreigne M, Izopet J, Tricoire J, Tran A, Pradier C, Bongain A. HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? AIDS 2007; 21: 1811-1815 [PMID: 17690581 DOI: 10.1097/QAD.0b013e3282703810]
42. Azzari C, Moriondo M, Indolfi G, Betti L, Gambineri E, de Martino M, Resti M. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol 2008; 80: 65-71 [PMID: 18041020 DOI: 10.1002/jmv.21023]
43. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014; 59: 765-773 [PMID: 24928290 DOI: 10.1093/cid/ciu447]
44. Yeung CY, Lee HC, Chan WT, Jiang CB, Chang SW, Chuang CK. Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol 2014; 6: 643-651 [PMID: 25276280 DOI: 10.4254/wjh.v6.i9.643]
45. England K, Pembrey L, Tovo PA, Newell ML. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 2005; 94: 444-450 [PMID: 16092459 DOI: 10.1111/j.1651-2227.2005.tb01916.x]
46. Pembrey L, Newell ML, Tovo PA, van Drimmelen H, Quinti I, Furlini G, Galli S, Meliconi MG, Burns S, Hallam N, Sönnerborg A, Cilla G, Serrano E, Laccetti P, Portella G, Polywka S, Icardi G, Bruzzone B, Balbo L, Alfarano A. Inter-laboratory comparison of HCV-RNA assay results: implications for multi-centre research. J Med Virol 2003; 69: 195-201 [PMID: 12683407 DOI: 10.1002/jmv.10283]
47. Polywka S, Pembrey L, Tovo PA, Newell ML. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 2006; 78: 305-310 [PMID: 16372293 DOI: 10.1002/jmv.20540]
48. Nie QH, Gao LH, Cheng YQ, Huang XF, Zhang YF, Luo XD, Wang JQ, Wang YY. Hepatitis C virus infection of human cytotrophoblasts cultured in vitro. J Med Virol 2012; 84: 1586-1592 [PMID: 22930506 DOI: 10.1002/jmv.23380]
49. Pelletier S, Drouin C, Bédard N, Khakoo SI, Bruneau J, Shoukry NH. Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol 2010; 53: 805-816 [PMID: 20688412 DOI: 10.1016/j.jhep.2010.05.013]
50. Alter G, Jost S, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, Altfeld M, Lauer GM. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance. J Hepatol 2011; 55: 278-288 [PMID: 21168454 DOI: 10.1016/j.jhep.2010.11.030]
51. Hurtado CW, Golden-Mason L, Brocato M, Krull M, Narkewicz MR, Rosen HR. Innate immune function in placenta and cord blood of hepatitis C-seropositive mother-infant dyads. PLoS One 2010; 5: e12232 [PMID: 20814429 DOI: 10.1371/journal. pone.0012232.2]
52. Manzin A, Solforosi L, Debiaggi M, Zara F, Tanzi E, Romanò L, Zanetti AR, Clementi M. Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection. J Virol 2000; 74: 4327-4334 [PMID: 10756048 DOI: 10.1128/JVI.74.9.4327-4334.2000]
53. Pollack H, Hou Z, Hughes AL, Borkowsky W. Perinatal transmission and viral evolution of hepatitis C virus quasispecies in infants coinfected with HIV. J Acquir Immune Defic Syndr 2004; 36: 890-899 [PMID: 15220695 DOI: 10.1097/00126334-20040801 0-00002]
54. Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection 2006; 34: 62-65 [PMID: 16703294 DOI: 10.1007/s15010-006-5037-4]
55. Austgen TR, Chen MK, Moore W, Souba WW. Endotoxin and renal glutamine metabolism. Arch Surg 1991; 126: 23-27 [PMID: 1670757 DOI: 10.1073/pnas.0602546103]
56. Honegger JR, Kim S, Price AA, Kohout JA, McKnight KL, Prasad MR, Lemon SM, Grakoui A, Walker CM. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 2013; 19: 1529-1533 [PMID: 24162814 DOI: 10.1038/nm.3351]
57. Mok J, Pembrey L, Tovo PA, Newell ML. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005; 90: F156-F160 [PMID: 15724041 DOI: 10.1136/adc.2004.059436]
58. Lin HH, Kao JH, Hsu HY, Ni YH, Yeh SH, Hwang LH, Chang MH, Hwang SC, Chen PJ, Chen DS. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994; 169: 638-641 [PMID: 8158040 DOI: 10.1093/infdis/169.3.638]
59. Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 2003; 187: 345-351 [PMID: 12552417 DOI: 10.1086/367704]
60. Tomura Y, Hisa H, Satoh S. Effects of atrial natriuretic peptide on phenylephrine-induced renin release in dogs. Clin Exp Pharmacol Physiol 1990; 17: 381-384 [PMID: 2141305 DOI: 10.1002/hep.24298.2011]
61. Murakami J, Nagata I, Iitsuka T, Okamoto M, Kaji S, Hoshika T, Matsuda R, Kanzaki S, Shiraki K, Suyama A, Hino S. Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 2012; 42: 648-657 [PMID: 22404371 DOI: 10.1111/j.1872-034X.2012.00968.x]
62. Cottrell EB, Chou R, Wasson N, Rahman B, Guise JM. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013; 158: 109-113 [PMID: 23437438 DOI: 10.7326/0 003-4819-158-2-201301150-00574]
63. Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 1997; 315: 333-337 [PMID: 9270453 DOI: 10.1136/bmj.315.7104.333]
64. Ruiz-Extremera A, Salmerón J, Torres C, De Rueda PM, Giménez F, Robles C, Miranda MT. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission. Pediatr Infect Dis J 2000; 19: 511-516 [PMID: 10877164]
65. Larouche A, Gaëtan G, El-Bilali N, Quesnel-Vallières M, Martin SR, Alvarez F, Shoukry NH, Soudeyns H. Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission. J Clin Microbiol 2012; 50: 2515-2519 [PMID: 22535990 DOI: 10.1128/JCM.00622-12]
66. Azzari C, Resti M, Moriondo M, Ferrari R, Lionetti P, Vierucci A. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 2000; 96: 2045-2048 [PMID: 10979945]
67. Papaevangelou V, Pollack H, Rochford G, Kokka R, Hou Z, Chernoff D, Hanna B, Krasinski K, Borkowsky W. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis 1998; 178: 1047-1052 [PMID: 9806033 DOI: 10.1086/515668]
68. Delotte J, Barjoan EM, Berrébi A, Laffont C, Benos P, Pradier C, Bongain A. Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med 2014; 27: 664-670 [PMID: 23971940 DOI: 10.3109/14767058.2013.829813]
69. Delamare C, Carbonne B, Heim N, Berkane N, Petit JC, Uzan S, Grangé JD. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol 1999; 31: 416-420 [PMID: 10488698 DOI: 10.1016/S0168-8278(99)80031-2]
70. Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33: 1341-1342 [PMID: 11343269 DOI: 10.1053/jhep.2001.0103305le02]
71. Inui A, Fujisawa T, Sogo T, Komatsu H, Isozaki A, Sekine I. Different outcomes of vertical transmission of hepatitis C virus in a twin pregnancy. J Gastroenterol Hepatol 2002; 17: 617-619 [PMID: 12084037 DOI: 10.1046/j.1440-1746.2002.02601.x]
72. Spencer JD, Latt N, Beeby PJ, Collins E, Saunders JB, McCaughan GW, Cossart YE. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997; 4: 395-409 [PMID: 9430360 DOI: 10.1046/j.1365-2893.1997.00073.x]
73. Okamoto M, Nagata I, Murakami J, Kaji S, Iitsuka T, Hoshika T, Matsuda R, Tazawa Y, Shiraki K, Hino S. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000; 182: 1511-1514 [PMID: 11023474 DOI: 10.1086/315883]
74. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356: 904-907 [PMID: 11036896 DOI: 10.1016/S0140-6736(00)02681-7]
75. Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV-mothers: a meta-analysis. Arch Gynecol Obstet 2011; 283: 255-260 [PMID: 20652289 DOI: 10.1007/s00404-010-1588-9]
76. Pembrey L, Newell ML, Tovo PA. The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 2005; 43: 515-525 [PMID: 16144064 DOI: 10.1016/j.jhep.2005.06.002]
77. Shiraki K, Ohto H, Inaba N, Fujisawa T, Tajiri H, Kanzaki S, Matsui A, Morishima T, Goto K, Kimura A, Hino S. Guidelines for care of pregnant women carrying hepatitis C virus and their infants. Pediatr Int 2008; 50: 138-140 [PMID: 18279227 DOI: 10.1111/j.1442-200X.2007.02518.x]
78. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59: 1-110 [PMID: 21160459]
79. Shaheen MA, Idrees M. Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease. World J Hepatol 2015; 7: 616-627 [PMID: 25848486 DOI: 10.4254/wjh.v7.i3.616]
80. Kage M, Ogasawara S, Kosai K, Nakashima E, Shimamatsu K, Kojiro M, Kimura A, Fujisawa T, Matsukuma Y, Ito Y, Kondo S, Kawano K, Sata M. Hepatitis C virus RNA present in saliva but absent in breast-milk of the hepatitis C carrier mother. J Gastroenterol Hepatol 1997; 12: 518-521 [PMID: 9257243 DOI: 10.1111/j.1440-1746.1997.tb00476.x]
81. Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R. Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis 1999; 29: 1327-1329 [PMID: 10524987 DOI: 10.1086/313473]
82. Azzari C, Indolfi G, Betti L, Moriondo M, Massai C, Becciolini L, Bertelli L, Poggi GM, De Martino M, Resti M. Vertical hepatitis C virus transmission is not related to mother-child class-1 HLA concordance. Int J Immunopathol Pharmacol 2000; 20: 827-831 [PMID: 18179755]
83. Bevilacqua E, Fabris A, Floreano P, Pembrey L, Newell ML, Tovo PA, Amoroso A. Genetic factors in mother-to-child transmission of HCV infection. Virology 2009; 390: 64-70 [PMID: 19481774 DOI: 10.1016/j.virol.2009.05.007]
84. Martinetti M, Pacati I, Cuccia M, Badulli C, Pasi A, Salvaneschi L, Minola E, De Silvestri A, Iannone AM, Maccabruni A. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 2006; 19: 369-378 [PMID: 16831303]
85. Resti M, Azzari C, Galli L, Zuin G, Giacchino R, Bortolotti F, Marcellini M, Moriondo M, de Martino M, Vierucci A. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002; 185: 567-572 [PMID: 11865412 DOI: 10.1086/339013]
86. Syriopoulou V, Nikolopoulou G, Daikos GL, Theodoridou M, Pavlopoulou I, Nicolaidou P, Manolaki N. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis 2005; 37: 350-353 [PMID: 16051571 DOI: 10.1080/00365540510032105]
87. Dowd KA, Hershow RC, Yawetz S, Larussa P, Diaz C, Landesman SH, Paul ME, Read JS, Lu M, Thomas DL, Netski DM, Ray SC. Maternal neutralizing antibody and transmission of hepatitis C virus to infants. J Infect Dis 2008; 198: 1651-1655 [PMID: 18928374 DOI: 10.1086/593067]
88. Meunier JC, Bukh J, Diaz G, Tovo PA, Casadei AM, Quinti I, Iorio R, Emerson S, Purcell RH, Farci P. Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively. J Infect Dis 2011; 204: 1741-1745 [PMID: 22006993 DOI: 10.1093/infdis/jir631]
89. Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, Landesman SH, Rubinstein A, Di Bisceglie AM, Goedert JJ. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998; 102: 355-359 [PMID: 9685438]
90. European Collaborative Study. Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children. AIDS 2004; 18: 509-516 [PMID: 15090804]
91. Galli L, Puliti D, Chiappini E, Gabiano C, Tovo PA, Pezzotti P, de Martino M. Lower mother-to-child HIV-1 transmission in boys is independent of type of delivery and antiretroviral prophylaxis: the Italian Register for HIV Infection in Children. J Acquir Immune Defic Syndr 2005; 40: 479-485 [PMID: 16280705]
92. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepère JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de Thé G, Moreau JP, Gessain A. Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 1999; 82: 832-836 [PMID: 10446450 DOI: 10.1002/(SIC I)1097-0215(19990909)82: 6]
93. Palomba E, Manzini P, Fiammengo P, Maderni P, Saracco G, Tovo PA. Natural history of perinatal hepatitis C virus infection. Clin Infect Dis 1996; 23: 47-50 [PMID: 8816128 DOI: 10.1093/clinids/23.1.47]
94. Tovo PA, Pembrey LJ, Newell ML. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J Infect Dis 2000; 181: 419-424 [PMID: 10669321 DOI: 10.1086/315264]
95. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, Zancan L, Pedditzi S, Bortolotti F. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003; 70: 373-377 [PMID: 12766999 DOI: 10.1002/jmv.1040]
96. Jonas MM. Children with hepatitis C. Hepatology 2002; 36: S173-S178 [PMID: 12407591 DOI: 10.1002/hep.1840360722]
97. Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, Kaye S, Ojuola O, Gillespie GM, Vargas Cuero AL, Cerundolo V, Callan M, McAdam KP, Rowland-Jones SL, Donner C, McMichael AJ, Whittle H. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003; 111: 1747-1755 [PMID: 12782677 DOI: 10.1172/JCI200317470]
98. Babik JM, Cohan D, Monto A, Hartigan-O’Connor DJ, McCune JM. The human fetal immune response to hepatitis C virus exposure in utero. J Infect Dis 2011; 203: 196-206 [PMID: 21288819 DOI: 10.1093/infdis/jiq044]
99. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41: 45-51 [PMID: 15937762 DOI: 10.1086/430601]
100. Yeung LT, To T, King SM, Roberts EA. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007; 14: 797-805 [PMID: 17927616 DOI: 10.1111/j.1365-2893.2007.00873.x]
101. Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, Marcellini M, Marazzi MG, Barbera C, Maggiore G, Vajro P, Bartolacci S, Balli F, Maccabruni A, Guido M. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-1907 [PMID: 18439604 DOI: 10.1053/j.gastro.2008.02.082]
102. Abdel-Hady M, Bunn SK, Sira J, Brown RM, Brundler MA, Davies P, Kelly DA. Chronic hepatitis C in children-review of natural history at a National Centre. J Viral Hepat 2011; 18: e535-e540 [PMID: 21914074 DOI: 10.1111/j.1365-2893.2011.01456.x]
103. Farmand S, Wirth S, Löffler H, Woltering T, Kenzel S, Lainka E, Henneke P. Spontaneous clearance of hepatitis C virus in vertically infected children. Eur J Pediatr 2012; 171: 253-258 [PMID: 21735055 DOI: 10.1007/s00431-011-1517-3]
104. Riche H, Chiara Y, Jaboulay JM. [Clinical outcome in the surgery of intracranial aneurysms: 229 cases]. Agressologie 1990; 31: 271-273 [PMID: 2288341 DOI: 10.1016/j.jpeds.2012.06.057]
105. Indolfi G, Mangone G, Calvo PL, Bartolini E, Regoli M, Serranti D, Calitri C, Tovo PA, de Martino M, Azzari C, Resti M. Interleukin 28B rs12979860 single-nucleotide polymorphism predicts spontaneous clearance of hepatitis C virus in children. J Pediatr Gastroenterol Nutr 2014; 58: 666-668 [PMID: 24792632 DOI: 10.1097/MPG.0000000000000275]
106. Indolfi G, Mangone G, Bartolini E, Nebbia G, Calvo PL, Moriondo M, Tovo PA, de Martino M, Azzari C, Resti M. Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data. PLoS One 2014; 9: e85899 [PMID: 24465773 DOI: 10.1371/journal.pone.0085899]
107. Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, Rosenthal P, Schwarz KB. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr 2012; 54: 838-855 [PMID: 22487950 DOI: 10.1097/MPG.0b013e318258328d]
108. González-Peralta RP, Langham MR, Andres JM, Mohan P, Colombani PM, Alford MK, Schwarz KB. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2009; 48: 630-635 [PMID: 19412012 DOI: 10.1097/MPG.0b013e318170af04]
109. England K, Pembrey L, Tovo PA, Newell ML. Growth in the first 5 years of life is unaffected in children with perinatally-acquired hepatitis C infection. J Pediatr 2005; 147: 227-232 [PMID: 16126055 DOI: 10.1016/j.jpeds.2005.04.010]
110. Pembrey L, Newell ML, Tovo PA. Age-related lymphocyte and neutrophil levels in children of hepatitis C-infected women. Pediatr Infect Dis J 2008; 27: 800-807 [PMID: 18664931 DOI: 10.1097/INF.0b013e31816ffc0e]
111. Kage M, Fujisawa T, Shiraki K, Tanaka T, Fujisawa T, Kimura A, Shimamatsu K, Nakashima E, Kojiro M, Koike M, Tazawa Y, Abukawa D, Okaniwa M, Takita H, Matsui A, Hayashi T, Etou T, Terasawa S, Sugiyama K, Tajiri H, Yoden A, Kajiwara Y, Sata M, Uchimura Y. Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology 1997; 26: 771-775 [PMID: 9303511 DOI: 10.1002/hep.510260333]
112. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28: 1416-1423 [PMID: 9794930 DOI: 10.1002/hep.510280534]
113. Mohan P, Barton BA, Narkewicz MR, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray KF, Haber B, Schwarz KB, Goodman ZD. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study. Hepatology 2013; 58: 1580-1586 [PMID: 23703847 DOI: 10.1002/hep.26519]
114. Larrubia JR, Moreno-Cubero E, Lokhande MU, García-Garzón S, Lázaro A, Miquel J, Perna C, Sanz-de-Villalobos E. Adaptive immune response during hepatitis C virus infection. World J Gastroenterol 2014; 20: 3418-3430 [PMID: 24707125 DOI: 10.3748/wjg.v20.i13.3418]
115. Gismondi MI, Becker PD, Díaz Carrasco JM, Guzmán CA, Campos RH, Preciado MV. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers. J Viral Hepat 2009; 16: 332-339 [PMID: 19228286 DOI: 10.1111/j.1365-2893.2009.01071.x]
116. Gaud U, Langer B, Petropoulou T, Thomas HC, Karayiannis P. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J Med Virol 2003; 69: 350-356 [PMID: 12526045 DOI: 10.1002/jmv.10296]
117. Canobio S, Guilbert CM, Troesch M, Samson J, Lemay M, Pelletier VA, Bernard-Bonnin AC, Kozielski R, Lapointe N, Martin SR, Soudeyns H. Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. J Clin Microbiol 2004; 42: 4365-4369 [PMID: 15365046 DOI: 10.1128/JCM.42.9.4365-4369.2004.120]
118. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39: 2-17 [PMID: 16884964 DOI: 10.1016/j.dld.2006.06.008]
119. Matsumoto S, Nakajima S, Nakamura K, Etani Y, Hirai H, Shimizu N, Yokoyama H, Kobayashi Y, Tajiri H, Shima M, Okada S. Interferon treatment on glomerulonephritis associated with hepatitis C virus. Pediatr Nephrol 2000; 15: 271-273 [PMID: 11149124]
120. Sugiura T, Yamada T, Kimpara Y, Fujita N, Goto K, Koyama N. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis. Pediatr Nephrol 2009; 24: 199-202 [PMID: 18696119 DOI: 10.1007/s00467-008-0948-1]
121. Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998; 112: 471-476 [PMID: 9649217 DOI: 10.1046/j.1365-2249.1998.00574.x]
122. Muratori P, Muratori L, Verucchi G, Attard L, Bianchi FB, Lenzi M. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 2003; 37: 1320-1326 [PMID: 14583865 DOI: 10.1086/379018]
123. Gehring S, Kullmer U, Koeppelmann S, Gerner P, Wintermeyer P, Wirth S. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha. World J Gastroenterol 2006; 12: 5787-5792 [PMID: 17007043 DOI: 10.3748/wjg.v12.i36.5787]
124. Bortolotti F, Muratori L, Jara P, Hierro L, Verucchi G, Giacchino R, Barbera C, Zancan L, Guido M, Resti M, Pedditzi S, Bianchi F, Gatta A. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr 2003; 142: 185-190 [PMID: 12584542 DOI: 10.1067/mpd.2003.45]
125. Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, Pasquale G, Venezia G, Craxì A, Almasio P. Does an ‘autoimmune’ profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004; 11: 257-262 [PMID: 15117328 DOI: 10.1111/j.1365-2893.2004.00489.x]
126. Indolfi G, Bartolini E, Olivito B, Azzari C, Resti M. Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection. Clin Dev Immunol 2012; 2012: 785627 [PMID: 226456232012 DOI: 10.1155/2012/785627]
127. Bretting H, Jacobs G, Müller S, Breitfeld O. The galactandegrading enzymes in the snail Biomphalaria glabrata. Comp Biochem Physiol B 1991; 99: 629-636 [PMID: 1769210 DOI: 10.1111/j.1365-2265.2007.03009.x]
128. Pham TN, Coffin CS, Michalak TI. Occult hepatitis C virus infection: what does it mean? Liver Int 2010; 30: 502-511 [PMID: 20070513 DOI: 10.1111/j.1478-3231.2009.02193.x]
129. Vidimliski PD, Nikolov I, Geshkovska NM, Dimovski A, Rostaing L, Sikole A. Review: Occult hepatitis C virus infection: still remains a controversy. J Med Virol 2014; 86: 1491-1498 [PMID: 24895180 DOI: 10.1002/jmv.23979]
130. Larrubia JR, Moreno-Cubero E, Miquel J, Sanz-de-Villalobos E. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. World J Gastroenterol 2015; 21: 3480-3491 [PMID: 25834312 DOI: 10.3748/wjg.v21. i12.3480]
131. Mohan P, Chandra RS, Escolar DM, Luban NL. Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease. Hepatology 2001; 34: 851-852 [PMID: 11584390 DOI: 10.1002/hep.510340439]
132. Ertekin V, Tan H. Opsoclonus-myoclonus syndrome attributable to hepatitis C infection. Pediatr Neurol 2010; 42: 441-442 [PMID: 20472199 DOI: 10.1016/j.pediatrneurol.2010.02.009]
133. Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 2015; 7: 725-737 [PMID: 25914773 DOI: 10.4254/wjh.v7.i5.725]